Abstract:Aim: Mitochondrial homeostasis is essential for maintaining redox balance. Besides canonical autophagy, Rab9-dependent alternative mitophagy is a crucial mechanism in metabolic cardiomyopathy. Here, we aim to investigate the role of alternative mitophagy and Beclin 1 haploinsufficiency (Beclin 1+/-) in high-fat diet (HFD)-induced metabolic cardiomyopathy. Results: 24-week HFD impaired glucose tolerance and cardiomyocyte contraction in WT mice, both of which were rescued in Beclin 1+/- mice. Beclin 1 haploinsufficiency had little effect on the conventional autophagy mediators (ATG5, LC3II/LC3I) but further upregulated Rab9 expression, a marker of alternative autophagy, in response to HFD challenge. Furthermore, either the inhibition of alternative autophagy or Beclin 1 haploinsufficiency abolished palmitic acid-induced cardiomyocyte contractile anomalies. In vitro, palmitic acid over-activated mitophagy, resulting in decreased mitochondrial content in H9C2 cells. These aberrations were alleviated in cells deficient in alternative autophagy but not in cells deficient in conventional autophagy. Mechanistically, HFD promoted ROS production, activated Rab9-dependent alternative mitophagy, and inhibited mitochondrial biosynthesis. Beclin 1+/- rescued HFD-induced ROS overflow, mitochondrial biogenesis impairment, and prevented Rab9 translocation from the cytoplasm to the mitochondria, thereby inhibiting Rab9-mediated mitophagy over-activation. Innovation: For the first time, this study suggests that prolonged alternative mitophagy exacerbates chronic HFD-induced cardiac dysfunction and supports the protective role of Beclin 1 haploinsufficiency in metabolic cardiomyopathy. This provides additional evidence for a target-based pharmacological intervention. Conclusions: Beclin 1 haploinsufficiency protects against HFD-induced cardiac dysfunction by inhibiting Rab9-dependent alternative mitophagy and ROS production, while promoting mitochondrial biogenesis. Modulating Beclin 1 expression holds promise in preventing chronic HFD-related cardiomyopathy.

11Β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Attenuates High-Fat Diet Induced Cardiomyopathy.

Discovery of Herbacetin As a Novel SGK1 Inhibitor to Alleviate Myocardial Hypertrophy

11β-HSD1 inhibition ameliorates diabetes-induced cardiomyocyte hypertrophy and cardiac fibrosis through modulation of EGFR activity.

11β-Hydroxysteroid Dehydrogenase Type 1(11β-HSD1) mediates insulin resistance through JNK activation in adipocytes

Essential roles of 11β-HSD1 in regulating brown adipocyte function.

Cardiac-Specific Down-Regulation Of Carnitine Palmitoyltransferase-1b (Cpt-1b) Prevents Cardiac Remodeling In Obese Mice

Role of 11-Beta-hydroxysteroid Dehydrogenase Type 1 in Differentiation of 3T3-L1 Cells and in Rats with Diet-Induced Obesity

Cardiospecific CD36 suppression by lentivirus-mediated RNA interference prevents cardiac hypertrophy and systolic dysfunction in high-fat-diet induced obese mice

11Β-Hydroxysteroid Dehydrogenase Type 1 Shrna Ameliorates Glucocorticoid-Induced Insulin Resistance and Lipolysis in Mouse Abdominal Adipose Tissue.

BVT.2733, a Selective 11Β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Attenuates Obesity and Inflammation in Diet-Induced Obese Mice.

Selective Inhibition of 11Β-Hydroxysteroid Dehydrogenase Type 1 Attenuates High-Fat Diet-Induced Hepatic Steatosis in Mice.

β-Hydroxybutyrate Mitigated Heart Failure with Preserved Ejection Fraction by Increasing Treg Cells via Nox2/GSK-3β

Chronic inhibition of 11beta‐hydroxysteroid dehydrogenase activity reduces cardiovascular comorbidities in corpulent and stroke‐prone SHR

Increased Angiogenesis Protects Against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11Β-Hydroxysteroid Dehydrogenase Type 1 (Hsd1)-Deficient Mice*

Expression and Significance of 11-Β Hydroxysteroid Dehydrogenase Type 1 in Rat Model with Metabolic Syndrome

Knockdown of 11Β-Hydroxysteroid Dehydrogenase Type 1 Alleviates LPS-induced Myocardial Dysfunction Through the AMPK/SIRT1/PGC-1α Pathway.

11Β-Hydroxysteroid Dehydrogenase Type 1 Amplifies Inflammation in LPS-induced THP-1 Cells.

Angiotensin II Type 1a Receptor Knockout Ameliorates High-Fat Diet-Induced Cardiac Dysfunction by Regulating Glucose and Lipid Metabolism

11 beta-hydroxysteroid dehydrogenase type 1 promotes differentiation of 3 T 3L 1 preadipocyte 1

Aldehyde Dehydrogenase-2 Attenuates Myocardial Remodeling and Contractile Dysfunction Induced by a High-Fat Diet.

Beclin-1 haploinsufficiency ameliorates high fat diet-induced myocardial injury via inhibiting alternative mitophagy